alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 51.25 Grievance procedure. ( a ) The P&A system shall establish procedures to address grievances from: ( 1 ) Clients or prospective clients of the P&A system to assure that individuals with mental illness have full access to the services of the program; and
( 2 ) Individuals who have received or are receiving mental health services in the State, family members of such individuals, or representatives of such individuals or family members to assure that the eligible P&A system is operating in compliance with the Act.
( b ) At a minimum, the grievance procedures shall provide for: ( 1 ) An appeal to the governing authority from any final staff review and/or determination; in cases where the governing authority is the director of the P&A system, the final review and/or determination shall be made by a superior of the governing authority, e.g., a supervisor, or by an independent entity, e.g., an appointed board or committee.
( 2 ) Reports, at least annually, to the governing authority and the advisory council describing the grievances received and processed and their resolution;
( 3 ) Identification of individuals responsible for review;
( 4 ) A timetable to ensure prompt notification concerning the grievance procedure to clients, prospective clients or persons denied representation, and to ensure prompt resolution;
( 5 ) A written response to the grievant; and
( 6 ) Protection of client confidentiality.
[62 FR 53564, Oct. 15, 1997]
I 

110TH CONGRESS 

1ST SESSION H. R. 2075 

To amend the Internal Revenue Code of 1986 to extend the new markets 

tax credit through 2013, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 30, 2007 

Mr. NEAL of Massachusetts (for himself, Mr. LEWIS of Kentucky, Mr. 

MCDERMOTT, Mr. ENGLISH of Pennsylvania, Mrs. JONES of Ohio, Mr. 

RAMSTAD, Mr. BLUMENAUER, Ms. PRYCE of Ohio, Mr. JEFFERSON, Mr. 

BISHOP of Georgia, and Mr. LUCAS) introduced the following bill; which 

was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to extend 

the new markets tax credit through 2013, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘New Markets Tax 

5 Credit Extension Act of 2007’’. 

6 SEC. 2. EXTENSION OF NEW MARKETS TAX CREDIT. 

7 (a) EXTENSION.— 


hmoore on PRODPC68 with HMBILLS
2 

•HR 2075 IH

1 (1) IN GENERAL.—Subparagraph (D) of section 

2 45D(f)(1) of the Internal Revenue Code of 1986 (re3 lating to national limitation on amount of invest4 ments designated) is amended by striking ‘‘2006, 

5 2007, and 2008’’ and inserting ‘‘each of calendar 

6 years 2006 through 2013’’. 

7 (2) CONFORMING AMENDMENT.—Section 

8 45D(f)(3) of such Code is amended by striking 

9 ‘‘2014’’ and inserting ‘‘2020’’. 

10 (b) INFLATION ADJUSTMENT.—Section 45D(f) of the 

11 Internal Revenue Code of 1986 is amended by inserting 

12 at the end the following new paragraph: 

13 ‘‘(4) INFLATION ADJUSTMENT.— 

14 ‘‘(A) IN GENERAL.—In the case of any cal15 endar year beginning after 2008, the dollar 

16 amount in paragraph (1)(D) shall be increased 

17 by an amount equal to— 

18 ‘‘(i) such dollar amount, multiplied by 

19 ‘‘(ii) the cost-of-living adjustment de20 termined under section 1(f)(3) for the cal21 endar year, determined by substituting 

22 ‘calendar year 2007’ for ‘calendar year 

23 1992’ in subparagraph (B) thereof. 

24 ‘‘(B) ROUNDING RULE.—If a dollar 

25 amount in paragraph (1)(D), as increased 


hmoore on PRODPC68 with HMBILLS
3 

•HR 2075 IH

1 under subparagraph (A), is not a multiple of 

2 $1,000,000, such amount shall be rounded to 

3 the nearest multiple of $1,000,000.’’. 

4 (c) EFFECTIVE DATE.—The amendments made by 

5 this section shall take effect on the date of the enactment 

6 of this Act. 

Æ 


hmoore on PRODPC68 with HMBILLS
----

            COMMISSION REGULATION (EC) No 243/2005

of 11 February 2005         

fixing the minimum selling prices for butter for the 157th individual invitation to tender under the standing invitation to tender provided for in Regulation (EC) No 2571/97

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EC) No 1255/1999 of 17 May 1999 on the common organisation of the market in milk and milk products (1), and in particular Article 10 thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

The minimum selling prices of butter from intervention stocks and processing securities applying for the 157th individual invitation to tender, under the standing invitation to tender provided for in Regulation (EC) No 2571/97, shall be fixed as indicated in the Annex hereto.

Article 2

This Regulation shall enter into force on 12 February 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 11 February 2005.

For the Commission

Mariann FISCHER BOEL            

Member of the Commission

----

(1)OJ L 160, 26.6.1999, p. 48. Regulation as last amended by Commission Regulation (EC) No 186/2004 (OJ L 29, 3.2.2004, p. 6).

(2)OJ L 350, 20.12.1997, p. 3. Regulation as last amended by Regulation (EC) No 2250/2004 (OJ L 381, 28.12.2004, p. 25).

----

ANNEX

to the Commission Regulation of 11 February 2005 fixing the minimum selling prices for butter for the 157th individual invitation to tender under the standing invitation to tender provided for in Regulation (EC) No 2571/97

----
#### STATE of Louisiana ex rel. Russell ALEXANDER v. 16TH JUDICIAL DISTRICT COURT, PARISH OF ST. MARY.

No. 65283.

Supreme Court of Louisiana.

Sept. 21, 1979.

In re Russell Alexander applying for writs of mandamus and certiorari. Parish of St. Mary.

Writ denied.
§ 67.10 Purpose and scope. The regulations of this subpart apply to the award by AHCPR of grants and cooperative agreements under: ( a ) Title IX of the Public Health Service Act to support research, evaluation, demonstration, and dissemination projects, including conferences, on health care services and systems for the delivery of such services, as well as to establish and operate multidisciplinary health services research centers.
( b ) Section 1142 of the Social Security Act to support research on the outcomes, effectiveness, and appropriateness of health care services and procedures, including but not limited to, evaluations of alternative services and procedures; projects to improve methods and data bases for outcomes, effectiveness, and other research; dissemination of research information and clinical guidelines, conferences, and research on dissemination methods.
§ 493.1103 Standard: Requirements for transfusion services. A facility that provides transfusion services must meet all of the requirements of this section and document all transfusion-related activities. ( a ) *Arrangement for services.* The facility must have a transfusion service agreement reviewed and approved by the responsible party(ies) that govern the procurement, transfer, and availability of blood and blood products.
( b ) *Provision of testing.* The facility must provide prompt ABO grouping, D(Rho) typing, unexpected antibody detection, compatibility testing, and laboratory investigation of transfusion reactions on a continuous basis through a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by CMS.
( c ) *Blood and blood products storage and distribution.* ( 1 ) If a facility stores or maintains blood or blood products for transfusion outside of a monitored refrigerator, the facility must ensure the storage conditions, including temperature, are appropriate to prevent deterioration of the blood or blood product.
( 2 ) The facility must establish and follow policies to ensure positive identification of a blood or blood product beneficiary.
( d ) *Investigation of transfusion reactions.* The facility must have procedures for preventing transfusion reactions and when necessary, promptly identify, investigate, and report blood and blood product transfusion reactions to the laboratory and, as appropriate, to Federal and State authorities.
Developed at

Sourcewater, Inc.

Joshua Adler, CEO

josh@sourcewater.com

www.sourcewater.com
Sourcewater is the Online Marketplace 

for Sourcing, Moving and Disposing of 

Water for Energy Production
!"#$%&'$(')*+,$-*"./%)*0$123$45)6*$78$9:)*&;'+$1"04<$$

<=56>)$?&@6'+$A)*B6%)$1"?:&'6)0$C9D($:*"E4&F>)G$
!6'4H$=5&4$C&@)0$35)0)$I>6@)G$
Do Your Plane Flights Look Like This?
Or Do Your Plane Flights Look Like This?
4"$E'.$45)$

!"#$%$0)&4G$

J"$,"/$%&>>$

&'&!($&6*>6')K$

&'&!($.&,K$$
)!*+,*(,-*-.&/

0$&*

120342305*

! L6'.$IB&6>&F6>64,$

! 1"?:&*)$-*6%)$

! -)*M"*?&'%)$D&;'+0$

! D"/;'+N36?)0$

! 1"?:&*)$J&4)0$

! L&*)$A&>)0$L6>>$->&')0$

&'.$A&B)$L>,)*0O$PPP$
Markets Work!
60$&$?&*@)4:>&%)$

=)$?&4%5$A2--QR$&'.$J(CISJ$

M"*$=I3(D$&'.$=I3(D$A(DTU1(A$
C&4%5)0$=&4)*$A"/*%)0K$20)0$V$3*&'0:"*4$

(V-$-*"./%).$=&4)*$

(V-$L*)05#&4)*$

3*)&4).$=&4)*$

=&4)*$2;>6;)0$V$-6:)>6')0$ L&*?0K$D&'%5)0K$Q&'."#')*0$

1"?:>);"'0$

J60:"0&>$

3*)&4?)'4$

L&*?0$

=&4)*$3*/%@6'+$

1"?:&'6)0$

=&4)*$3*&'0M)*$

1"?:&'6)0$

=&4)*$A"/*%)0$ =&4)*$20)0$

S"'WL*)05#&4)*$L>"#0$

L*)05#&4)*$L>"#0$
A Marketplace Helps E&P Buyers

! Cut Water Management Cost – #1 OpEx for Energy Producers

" Cut water hauling distance

" Discounted same-day and advanced fares

" Find low cost non-freshwater sources, get paid to recycle

" Eliminate take-or-pay obligations

! Ensure Supply Chain Against Disruptions

! Save Time and Improve Results (replace phone calls w/ Internet)

! Monetize Excess Capacity

! Minimize Environmental & Community Impacts
A Marketplace Helps Water Sellers & Services

! Max Utilization & Profitability (sell the last seat on every flight)

! Cut Sales & Marketing Cost (all buyers in one place)

! Ensure Fair Value 

! Enable Financing & Underwriting (price = if, where, how much)

! Spot & Futures Market = Less Risk (safety, hedging, backups)
CASE STUDY: JOE, E&P Production Manager 

Has

50,000 BBL

For Disposal

In 100k BBL Pit
JANE Disposal Well Manager

HAS

50,000 BBL

Unsold Capacity

Today
Jane Creates Disposal for Sale on Sourcewater
Joe finds Jane’s Fare Sale

JOE

Production 

Manager

JANE

Disposal

Manager

!&0$XY@$ZZQ$-*"./%).$6'$

8YY@$ZZQ$-64$

U'04)&.$"M$:&,6'+$M/>>$

:*6%)$&[)*$#&6;'+$M"*$

M/>>$:64$5)$:&,0$5&>M$:*6%)$

4"$)?:4,$5&>M$:64$

Q&04W?6'/4)$%&'%)>>&;"'$$\$

36?)$M"*$&$L&*)$A&>)]$

Z)^)*$4"$+)4$P8NZZQ$4".&,$

"'$XY@$ZZQ0$45&'$+)4$P_N

ZZQ$4".&,$"'$`)*"$ZZQ0a$

b")$4&@)0$P8NZZQ$L&*)$A&>)$D&4)$

L"*$5&>M$:64$.60:"0&>$6'04)&.$"M$

P_NZZQ$M/>>$*&4)$

6,&*.7'&.*89:;<<<*0,+7(*

b&')$*)%)6B)0$P8NZZQ$M"*$XY@$ZZQ$

6'04)&.$"M$P_NZZQ$M"*$c)*"$ZZQ

67=&*>7?&.*8:<;<<<*0,+7(*

/"=.%&7+*,@*2,%$"=#

A12*B*A125*
Status: LIVE!

1.15 Billion BBL H2O Listed Now

75+ Registered Users
Sourcewater, Inc.

Joshua Adler, CEO

josh@sourcewater.com

www.sourcewater.com

!"##$%&$'()%$*$)#+",-.

C&&*7*D&>,*7=+*C"#=*EF*G!&&*2,H5*
#### Seven Mile Beach Company, respondent, *v.*Charles S. Dolley et al., appellants.

[Argued. June 29th, 1906.

Decided March 4th, 1907.]

On cross-appeal by defendants from a decree of tbe conrt of chancery, advised by Vice-Chancellor Bergen, whose opinion is reported *ante p. 7S6.*

*Mr. Norman*Grey, for the appellants.

*Mr. Lewis Stcurr*and *Mr. Clarence L.*Cole, for the respondent.

Per Curiam.

So mnch of the decree in this canse as is brought np for review by the appeal taken by the defendants below is affirmed, for the reasons stated in the opinion filed by Vice-Chancellor Bergen in the conrt below.

*For*affirmance—The Chiee-Justice, Garrison, Fort, Hendrickson, Pitney, Swayze, Reed, Trenohard, Bogert, Vre-DENBURGH, VrOOM, GREEN, GRAY, DlLL—14.

*For*reversal—None.
<TABLE> <S> <C>


<ARTICLE>                                           BD
<LEGEND>
              This schedule contains summary financial information extracted 
from the Consolidated Statement of Financial Condition at August 31, 1997 
(Unaudited) and the  Consolidated  Statement of Operations  for the nine months 
ended August 31, 1997 (Unaudited) and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<MULTIPLIER>                                   1,000,000
       
<S>                                           <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              NOV-30-1997
<PERIOD-START>                                 DEC-01-1996
<PERIOD-END>                                   AUG-31-1997
<CASH>                                         1,034
<RECEIVABLES>                                  11,822
<SECURITIES-RESALE>                            48,872
<SECURITIES-BORROWED>                          15,212
<INSTRUMENTS-OWNED>                            36,111
<PP&E>                                         267
<TOTAL-ASSETS>                                 113,697
<SHORT-TERM>                                   758
<PAYABLES>                                     21,827
<REPOS-SOLD>                                   53,943
<SECURITIES-LOANED>                            10,124
<INSTRUMENTS-SOLD>                             18,787
<LONG-TERM>                                    4,285
<COMMON>                                       0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<OTHER-SE>                                     1,892
<TOTAL-LIABILITY-AND-EQUITY>                   113,697
<TRADING-REVENUE>                              579
<INTEREST-DIVIDENDS>                           9,224
<COMMISSIONS>                                  247
<INVESTMENT-BANKING-REVENUES>                  697
<FEE-REVENUE>                                  0
<INTEREST-EXPENSE>                             8,897
<COMPENSATION>                                 1,010
<INCOME-PRETAX>                                266
<INCOME-PRE-EXTRAORDINARY>                     190
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   190
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        


                                                           



</TABLE>
§ 93.304 Institutional policies and procedures. Institutions seeking an approved assurance must have written policies and procedures for addressing research misconduct that include the following— ( a ) Consistent with § 93.108, protection of the confidentiality of respondents, complainants, and research subjects identifiable from research records or evidence;
( b ) A thorough, competent, objective, and fair response to allegations of research misconduct consistent with and within the time limits of this part, including precautions to ensure that individuals responsible for carrying out any part of the research misconduct proceeding do not have unresolved personal, professional, or financial conflicts of interest with the complainant, respondent, or witnesses;
( c ) Notice to the respondent, consistent with and within the time limits of this part;
( d ) Written notice to ORI of any decision to open an investigation on or before the date on which the investigation begins;
( e ) Opportunity for the respondent to provide written comments on the institution's inquiry report;
( f ) Opportunity for the respondent to provide written comments on the draft report of the investigation, and provisions for the institutional investigation committee to consider and address the comments before issuing the final report;
( g ) Protocols for handling the research record and evidence, including the requirements of § 93.305;
( h ) Appropriate interim institutional actions to protect public health, Federal funds and equipment, and the integrity of the PHS supported research process;
( i ) Notice to ORI under § 93.318 and notice of any facts that may be relevant to protect public health, Federal funds and equipment, and the integrity of the PHS supported research process;
( j ) Institutional actions in response to final findings of research misconduct;
( k ) All reasonable and practical efforts, if requested and as appropriate, to protect or restore the reputation of persons alleged to have engaged in research misconduct but against whom no finding of research misconduct is made;
( l ) All reasonable and practical efforts to protect or restore the position and reputation of any complainant, witness, or committee member and to counter potential or actual retaliation against these complainants, witnesses, and committee members; and
( m ) Full and continuing cooperation with ORI during its oversight review under Subpart D of this part or any subsequent administrative hearings or appeals under Subpart E of this part. This includes providing all research records and evidence under the institution's control, custody, or possession and access to all persons within its authority necessary to develop a complete record of relevant evidence.
HomeOffice of the SpokespersonPress Releases...Proliferation Security Initiative’s 20th Anniversary and High-Level Political Meeting

# 									Proliferation Security Initiative’s 20th Anniversary and High-Level Political Meeting							

Press Statement

Matthew Miller, Department Spokesperson

June 2, 2023

The Republic of Korea hosted the High-Level Political Meeting in commemoration of the 20th anniversary of the Proliferation Security Initiative (PSI) on May 30, 2023.  This meeting reviewed the actions implemented by PSI-endorsing States over the past 20 years, assessed the proliferation challenges we face presently and provided direction to PSI to meet these challenges over the next five years.

As a Presidential Initiative, the PSI, which currently has 106 participating countries, has been strongly supported by every U.S. administration since the Initiative’s inception and remains a key element of the global weapons of mass destruction nonproliferation regime.  The United States encourages all states that support the Initiative’s counterproliferation goals, including interdicting illicit shipments of WMD, their delivery systems, and related items, to join the PSI by endorsing the PSI Statement of Interdiction Principles and participating in future PSI events and activities.

Tags

Bureau of East Asian and Pacific AffairsBureau of International Security and NonproliferationOffice of Counterproliferation InitiativesOffice of the SpokespersonProliferationSecuritySouth KoreaWeapons of Mass Destruction

Back to Top
----

            DECISION OF THE EEA JOINT COMMITTEE         

No 95/2004

of 9 July 2004         

amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

HAS DECIDED AS FOLLOWS:

Article 1

Chapter I of Annex I to the Agreement shall be amended as specified in the Annex to this Decision.

Article 2

The texts of Directive 2003/74/EC and Decisions 2003/380/EC, 2003/470/EC and 2003/721/EC in the Norwegian language, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 10 July 2004, provided that all the notifications under Article 103 (1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 9 July 2004.

For the EEA Joint Committee

The President

Kjartan JÓHANNSSON            

----

(1)OJ L 349, 25.11.2004, p. 23.

(2)OJ L 131, 28.5.2003, p. 18.

(3)OJ L 157, 26.6.2003, p. 66.

(4)OJ L 260, 11.10.2003, p. 21.

(5)OJ L 262, 14.10.2003, p. 17.

(*1)  No constitutional requirements indicated.

----

ANNEX

to Decision of the EEA Joint Committee No 95/2004

Chapter I of Annex I to the Agreement shall be amended as specified below:

----
#### § 7.6 Exemptions.

State and local health departments, governmental institutions (e.g., State hospitals and universities), the World Health Organization, and ministries of health of foreign governments may be exempted from paying user charges, when using biological standards or biological preparations for public health purposes.
#### § 51c.113 Applicability of 45 CFR part 75.

The provisions of 45 CFR part 75, establishing uniform administrative requirements and cost principles, shall apply to all grants under this part.

[81 FR 3007, Jan. 20, 2016]
COURT OF APPEALS

	SECOND DISTRICT OF TEXAS

	FORT WORTH

	NO. 2-05-330-CV

SOCORRO RODRIGUEZ	APPELLANT

	V.

THE CLINIC FOR SPECIAL SURGERY	APPELLEE

	------------

	FROM THE 153RD DISTRICT COURT OF TARRANT COUNTY

	------------

	MEMORANDUM OPINION1

	------------

	On September 15, 2005, we notified appellant that we may not have jurisdiction over this appeal because it was not timely filed.  See Tex. R. App. P. 26.1.  We also stated that unless appellant or any party desiring to continue the appeal filed with this court, on or before September 26, 2005, a response showing grounds for continuing the appeal, we would dismiss the appeal for want of jurisdiction.  See Tex. R. App. P. 42.3(a).  We have not received any response.

	Accordingly, we dismiss the appeal for want of jurisdiction.  See Tex. R. App. P. 42.3(a), 43.2(f).

							PER CURIAM

PANEL D:	LIVINGSTON, DAUPHINOT, and HOLMAN, JJ.

DELIVERED:  October 20, 2005
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 96-50269

Conference Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

RAMON ALBERTO PADILLA-GALLARDO,

a.k.a. Danny Sabalas

Defendant-Appellant.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Texas

USDC No. A-95-CR-190

- - - - - - - - - -

October 24, 1996

Before POLITZ, Chief Judge, and JOLLY and HIGGINBOTHAM, Circuit Judges.

PER CURIAM:*

Ramon Alberto Padilla-Gallardo appeals the sentence imposed

subsequent to his plea of guilty to reentry into the United

States after deportation. Padilla-Gallardo first argues that the

district court erred in using the statutory maximum of 18 U.S.C.

§ 1326(b)(2) because the indictment did not allege that his

deportation had been subsequent to the commission of an
No. 96-50269

- 2 -

aggravated felony. Title 18 U.S.C. § 1326(b) is a sentence

enhancement provision rather than an independent criminal

offense; thus, it need not be alleged in the indictment. United

States v. Vasquez-Olvera, 999 F.2d 943, 945 (5th Cir. 1993), cert

denied, 510 U.S. 1076 (1994). In his reply brief, PadillaGallardo invites the court to reconsider its decision in VasquezOlvera en banc. We decline to consider the request as it is

untimely under Rule 35 of the Federal Rules of Civil Procedure

and does not comply with this court’s local rules. See 5th Cir.

R. 35.2.

Padilla-Gallardo next argues that the court erred in denying

him a two-level reduction for acceptance of responsibility. It

was not clear error for the district court to determine that

Padilla-Gallardo’s statements to an INS agent and other behavior

were inconsistent with his acceptance of responsibility. 

U.S.S.G. § 3E1.1, comment. (n.3).

AFFIRMED.
#### Eric L. GANT, petitioner, v. UNITED STATES.

No. 05-6740.

Nov. 28, 2005.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.